Soluble LAG-3 binding to cancer cells - influence of cell types, MHC class II and lipid rafts

Smith, Kendra Laura (2024) Soluble LAG-3 binding to cancer cells - influence of cell types, MHC class II and lipid rafts. Masters thesis, Memorial University of Newfoundland.

[img] [English] PDF - Accepted Version
Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission.

Download (3MB)

Abstract

Interaction of immunoinhibitory molecules, lymphocyte activating gene-3 (LAG-3) and programmed cell death protein-1 (PD-1) on tumor infiltrating lymphocytes with their respective ligands, contributes to an exhausted immune phenotype. However, soluble LAG-3 (sLAG-3) enhances immunity by inducing dendritic cell maturation by binding MHC-II associated with lipid rafts. The first part of this thesis assessed the importance of MHC-II/lipid rafts versus peptide/MHC-II complexes (pMHC-II) as sLAG-3 ligands. Analysis of sLAG-3 binding to B-cell lines was done using flow cytometry. Results indicated stable pMHC-II play a larger role in sLAG-3 binding than incorporation of pMHC-II in lipid rafts. sLAG-3 binding, MHC-II, CD59 and PD-L1 were assessed by flow cytometry on IFN-γ treated melanoma cell line (MDA-MB-435) and different breast cancer cell lines (BCCL). Lipid raft disruptor, methyl-B-cyclodextrin was used to treat cell lines to determine if LAG-3 binding was affected by lipid rafts. Cell lines were MHC-II⁺ and PD-L1⁺, but only MDA-MB-435 bound sLAG3. Deficient LAG-3 binding to BCCL could not be explained by HLA-DM or lipid raft deficiency. Lipid raft disruption increased sLAG-3 binding, this could not be explained by MHC-II or CD59. This suggests that lipid raft disruption may expose MHC-II and other ligands to promote sLAG-3 binding. Altogether, results indicate LAG-3 binding is cell-context dependent and more complex than simply binding p/MHC-II complexes, preferentially located in lipid rafts.

Item Type: Thesis (Masters)
URI: http://research.library.mun.ca/id/eprint/16421
Item ID: 16421
Additional Information: Includes bibliographical references (pages 94-106)
Keywords: LAG-3, lipid rafts, breast cancer
Department(s): Medicine, Faculty of > Biomedical Sciences
Date: May 2024
Date Type: Submission
Medical Subject Heading: Breast Neoplasms; Programmed Cell Death 1 Receptor; Lymphocytes, Tumor-Infiltrating; B7-H1 Antigen; Dendritic Cells; Peptides

Actions (login required)

View Item View Item

Downloads

Downloads per month over the past year

View more statistics